ArticleThe Journal of clinical investigation2022

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.

Shuang G Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.